This reduction in CX3CL1 levels subsequently decreases monocyte adhesion, thereby mitigating inflammation and thrombosis [26,27]. Thrombosis can lead to damage in multiple organs, including the liver, heart, and kidneys. This evidence concerns the gene CX3CL1 and Venous thrombosis.